Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
psilocybin (SYNP-101) / Ceruvia Lifesci
NCT03341689: Psilocybin for the Treatment of Migraine Headache	Completed	1	14	US	High Dose Psilocybin, Low Dose Psilocybin, Placebo	Yale University, Ceruvia Lifesciences	Migraine Headache	04/21	10/21
NCT02981173: Psilocybin for the Treatment of Cluster Headache	Completed	1	25	US	0.143 mg/kg Psilocybin or 10 mg Psilocybin, 0.0143 mg/kg Psilocybin or 1 mg Psilocybin, Placebo	Yale University, Heffter Research Institute, Ceruvia Lifesciences, CH TAC LLC	Cluster Headache	06/22	10/22